This acclaimed text continues to focus on the essential techniques for effective surgical management of patients with ovarian cancer and related peritoneal surface malignancies. With a wealth of accompanying illustrations and operative videos; this fourth edition reflects the evolution - and controversies - in the use of minimally invasive and robotic surgery and the introduction of HIPEC treatment options.
This fourth edition of an acclaimed text focuses on the essential techniques for effective management of patients with ovarian cancer and related peritoneal surface malignancies, with a wealth of accompanying illustrations and operative videos, including minimally invasive and robotic surgery options and the introduction of HIPEC treatment.
Arvustused
"...amply meets its goals and fulfills a need for a comprehensive text."
- Doody's Review Service
"The updates in this fourth edition of a classic textbook amply justify its publication. The book has been thoroughly revised throughout, and several topics have been expanded."
- Carol Scott-Conner, MD, PhD, MBA, University of Iowa Hospitals and Clinics
1. Historical development of cytoreductive surgery for ovarian cancer
and scientific update.2. Epidemiology, staging, and clinical characteristics.
3. Preoperative risk stratification and intraoperative supportive care.4.
Instrumentation, retractors, ablative technologies and techniques, set-up and
conduct of operation.5. Management of Early-Stage Ovarian Cancer.6.
Cytoreductive surgery: Principles and rationale.
7. Predicting Surgical
Outcome: Patient Selection for Initial Surgery or Chemotherapy.
8.
Cytoreductive Surgery: Pelvis and Radical Oophorectomy.
9. Cytoreductive
surgery: Abdominal retroperitoneum and adenopathy.
10. Cytoreductive surgery:
Intestinal tract and Omentum.11. Cytoreductive surgery: Right upper
abdomenDiaphragm.
12. Cytoreductive surgery: Right upper abdomenLiver,
gallbladder, and porta hepatis.
13. Cytoreductive surgery: Left upper
quadrant.
14. Peritonectomy procedures for ovarian cancer.
15. Regional
Therapeutics and Peritonectomy Procedures for Ovarian Cancer. Robert
DeBernardo.
16. Secondary cytoreductive surgery.
17. Minimally Invasive
Surgery in Ovarian Cancer.
18. Palliative surgery for ovarian cancer.
19.
Postoperative management.
20. Quality indicators for ovarian cancer surgery.
21. Ovarian Cancer Surgery in Low Resource Settings: Global Health Program
Development Infrastructure.
Robert E Bristow MD MBA is Professor and Chair of the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine Medical Center in Orange, California, USA. Professor Bristows primary clinical and research interests include the surgical management of advanced-stage gynecologic cancer and the patterns of health care delivery for women with gynecologic cancer. Dr. Bristow is extensively published in the field of ovarian cancer surgical research and he is also a deputy editor of the journal Gynecologic Oncology. Beth Y Karlan MD is Director of the Womens Cancer Research Institute and the Division of Gynecologic Oncology at Cedars-Sinai Medical Center and Professor of Obstetrics and Gynecology at the David Geffen School of Medicine at the University of California, Los Angeles, California, USA. Professor Karlans research interests include molecular biomarker discovery, inherited cancer susceptibility and translational research efforts focused towards innovative treatment strategies for ovarian cancer. She has served as President of the Society of Gynecologic Oncologists and in 2006 was named an American Cancer Society Early Detection Clinical Research Professor. Professor Karlan is the Editor-in-Chief of Gynecologic Oncology. Dennis S Chi MD is Professor and Deputy Chief of the Gynecology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. Dr Chis primary research interests include the correlation of radiographic evaluation and operative findings in gynecologic malignancies and the utilization of innovative and advanced surgical techniques to improve outcomes for women with early, advanced, or recurrent gynecologic cancers. He is on the editorial board of the journals Journal of Oncology and The Oncologist and has served as the president of the Society of Memorial Gynecologic Oncologists and the Metropolitan Gynecologic Cancer Society.
Lisainfo e-raamatute kohta